LLY vs TAK: Stock Research Comparison
A side-by-side look at Eli Lilly and Company (LLY) and Takeda Pharmaceutical Company (TAK) on factual company data. Valarn runs the same multi-agent AI research — fundamentals, news, sentiment, valuation, and a structured bull-vs-bear debate — on each. Educational research, not advice.
| Sector | Healthcare | Healthcare |
|---|---|---|
| Industry | Drug Manufacturers - General | Drug Manufacturers - Specialty & Generic |
| Headquarters | Indianapolis, IN, US | Tokyo, OS, JP |
| Exchange | NYSE | NYSE |
| IPO year | 1972 | 2010 |
| Employees | 50,000 | 47,029 |
This comparison uses factual company reference data and is for informational and educational purposes only. It is not investment advice, and not a recommendation to buy, sell, or hold any security. Always do your own due diligence.